Welcome : Guest

Proteostasis Therapeutics, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Proteostasis Therapeutics, Inc., which is principally a Biopharmaceutical Company. Illustrated with 9 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-66277
Price: $450
Company Type: Public
Pages: 13
Date: January 2017
Market Data Tables: 9

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Cystic Fibrosis......5
Table 1: Drugs for Treatment of Cystic Fibrosis Market Worldwide (2015) in US$ Million......5
Table 2: Cystic Fibrosis (CF) Patient Population by Region Worldwide (2015) - Percentage Share Breakdown by Value for Australia, Canada, Rest of Europe, United Kingdom and USA......6
Parkinson's......7
Table 3: Parkinson's Market by Type Worldwide (2015) - Percentage Breakdown by Volume for Mild, Moderate and Severe......7
Table 4: Population Affected with Parkinson's by Age Group in the US (2015) - Percentage Share Breakdown for 65‐69, 70‐74, 75‐79, 80‐84 and 85+......8
Chronic Obstructive Pulmonary Disease (COPD) Drugs......9
Table 5: Chronic Obstructive Pulmonary Disease (COPD) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, North America and Rest of the World......9
Table 6: Chronic Obstructive Pulmonary Disease (COPD) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Long Acting Muscarinic Antagonists (LAMA), Long Acting Muscarinic Antagonists (LAMA) and Long Acting β2-Agonists (LABA), and Long Acting β2-Agonists (LABA) and Inhaled Corticosteroid (ICS)......10
Table 7: No. of Chronic Obstructive Pulmonary Disease (COPD) Patients Worldwide (2015) - Percentage Market Share Breakdown for Europe, North America, and Rest of World......11
Table 8: Chronic Obstructive Pulmonary Disease (COPD) and Asthma Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Flixotide and Flovent, Seretide and Advair, Spiriva, Symbicort, Xolair, and Others......12
Alzheimer Disease Therapeutic......13
Table 9: Market Shares of Leading Alzheimer Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Forest Laboratories, Inc., Johnson & Johnson, Novartis International AG, Pfizer, Inc., and Others......13